Salivary biomarkers for clinical applications

Molecular Diagnosis and Therapy

Volumn 13, Issue 4, 2009, Pages 245-259

  Zhang, Lei ^a   Xiao, Hua ^a   Wong, David T ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; BIOLOGICAL MARKER; CA 125 ANTIGEN; CALCIUM BINDING PROTEIN; CARBONATE DEHYDRATASE IV; CARCINOEMBRYONIC ANTIGEN; CATALASE; CD59 ANTIGEN; CYSTATIN C; CYTOKERATIN 19 FRAGMENT; DEFENSIN; ENDOTHELIN 1; FIBRONECTIN; HERMES ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LA ANTIBODY; LACTOFERRIN; PROFILIN; RO ANTIBODY; SALIVA PROTEIN; SOMATOSTATIN 14; TISSUE POLYPEPTIDE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

CANCER DIAGNOSIS; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SURVEILLANCE; GENETIC POLYMORPHISM; HEAD AND NECK CARCINOMA; HEALTH STATUS; HUMAN; IMMUNOASSAY; KNOWLEDGE BASE; MOUTH CARCINOMA; MOUTH DISEASE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SALIVA; SALIVARY GLAND; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BIOLOGICAL MARKERS; GENOMICS; HUMANS; MOUTH DISEASES; PROTEOMICS; SALIVA;

EID: 69349104464     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.2165/11317160-000000000-00000     Document Type: Review

References (159)

1. The Wong Lab, Dental Research Institute, UCLA School of Dentistry. Salivaomics knowledge base [online]. Available at URL: http://www.skb.ucla.edu [Accessed 2009 Jul 27]
2. Chittenden RH, Mendel LB, Jackson HC. A further study of the influence of alcohol and alcoholic drinks upon digestion, with special reference to secretion. Am J Physiol 1898; 1: 164-209
3. Kirk EC. Saliva as an index of faulty metabolism. Dent Dig 1903; 9: 1126-1138
4. Maliszewski TF, Bass DE. True and apparent thiocyanate in body fluids of smokers and nonsmokers. J Appl Physiol 1955 Nov; 8 (3): 289-291
5. Edwards DA, Fletcher K, Rowlands EN. Antagonism between perchlorate, iodide, thiocyanate, and nitrate for secretion in human saliva; analogy with the iodide trap of the thyroid. Lancet 1954 Mar 6; 266 (6810): 498-499
6. Tannenbaum SR, Sinskey AJ, Weisman M, et al. Nitrite in human saliva: its possible relationship to nitrosamine formation. J Natl Cancer Inst 1974 Jul; 53 (1): 79-84
7. Mandel ID. Dentistry 1980-1989: a profession in transition. Percy T. Phillips memorial lecture - 1990. N Y State Dent J 1990 Aug-Sep; 56 (7): 30-32
8. Swanson M, Cacace L, Chun G, et al. Saliva calcium and potassium concentrations in the detection of digitalis toxicity. Circulation 1973 Apr; 47 (4): 736-743
9. de Gier JJ, 't Hart BJ, Wilderink PF, et al. Comparison of plasma and saliva levels of diazepam. Br J Clin Pharmacol 1980 Aug; 10 (2): 151-155
10. Knott C, Hamshaw-Thomas A, Reynolds F. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy. Br Med J (Clin Res Ed) 1982 Jan 2; 284 (6308): 13-16 (Pubitemid 12175692)
11. Jarrett RF, Clark DA, Josephs SF, et al. Detection of human herpesvirus-6 DNA in peripheral blood and saliva. J Med Virol 1990 Sep; 32 (1): 73-76
12. Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995 Oct 20; 270 (5235): 467-470
13. Li Y, Zhou X, St John MA, et al. RNA profiling of cell-free saliva using microarray technology. J Dent Res 2004 Mar; 83 (3): 199-203 (Pubitemid 41715238)
14. Li Y, St John MA, Zhou X, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004 Dec 15; 10 (24): 8442-8450 (Pubitemid 40053408)
15. Mandel ID. Salivary diagnosis: promises, promises. Ann N Y Acad Sci 1993 Sep 20; 694: 1-10
16. Veenstra TD, Conrads TP, Hood BL, et al. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 2005 Apr; 4 (4): 409-418
17. Service RF. Proteomics: proteomics ponders prime time. Science 2008 Sep 26; 321 (5897): 1758-1761
18. Hu S, Loo JA, Wong DT. Human saliva proteome analysis and disease biomarker discovery. Expert Rev Proteomics 2007 Aug; 4 (4): 531-538
19. Hu S, Yen Y, Ann D, et al. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery. Drug Discov Today 2007 Nov; 12 (21-22): 911-916 (Pubitemid 350052672)
20. Denny P, Hagen FK, Hardt M, et al. The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res 2008 May; 7 (5): 1994-2006
21. Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics 2006 Dec; 6 (23): 6326-6353 (Pubitemid 44935518)
22. Yates 3rd JR. Mass spectral analysis in proteomics. Annu Rev Biophys Biomol Struct 2004; 33: 297-316
23. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003 Mar 13; 422 (6928): 198-207
24. Huang CM. Comparative proteomic analysis of human whole saliva. Arch Oral Biol 2004 Dec; 49 (12): 951-962
25. Hirtz C, Chevalier F, Centeno D, et al. Complexity of the human whole saliva proteome. J Physiol Biochem 2005 Sep; 61 (3): 469-480 (Pubitemid 43091765)
26. Hu S, Xie Y, Ramachandran P, et al. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 2005 Apr; 5 (6): 1714-1728 (Pubitemid 40593277)
27. Walz A, Stuhler K, Wattenberg A, et al. Proteome analysis of glandular parotid and submandibular-sublingual saliva in comparison to whole human saliva by two-dimensional gel electrophoresis. Proteomics 2006 Mar; 6 (5): 1631-1639
28. Hu S, Denny P, Xie Y, et al. Differentially expressed protein markers in human submandibular and sublingual secretions. Int J Oncol 2004 Nov; 25 (5): 1423-1430
29. Xie H, Rhodus NL, Griffin RJ, et al. A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol Cell Proteomics 2005 Nov; 4 (11): 1826-1830 (Pubitemid 41749274)
30. Guo T, Rudnick PA, Wang W, et al. Characterization of the human salivary proteome by capillary isoelectric focusing/nanoreversed-phase liquid chromatography coupled with ESI-tandem MS. J Proteome Res 2006 Jun; 5 (6): 1469-1478 (Pubitemid 43865815)
31. St John MA, Li Y, Zhou X, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004 Aug; 130 (8): 929-935 (Pubitemid 39045599)
32. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin 2000 Jan-Feb; 50 (1): 7-33
33. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005 Mar-Apr; 55 (2): 74-108
34. Hu S, Arellano M, Boontheung P, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008 Oct 1; 14 (19): 6246-6252
35. Chen YC, Li TY, Tsai MF. Analysis of the saliva from patients with oral cancer by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2002; 16 (5): 364-369 (Pubitemid 34174673)
36. Mizukawa N, Sugiyama K, Fukunaga J, et al. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res 1998 Nov-Dec; 18 (6B): 4645-4649 (Pubitemid 29042038)
37. Rhodus NL, Ho V, Miller CS, et al. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 2005; 29 (1): 42-45 (Pubitemid 40283497)
38. Fingleton B, Menon R, Carter KJ, et al. Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacy. Clin Cancer Res 2004 Dec 1; 10 (23): 7865-7874 (Pubitemid 39587525)
39. Franzmann EJ, Reategui EP, Carraway KL, et al. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev 2005 Mar; 14 (3): 735-739
40. Negri L, Pacchioni D, Calabrese F, et al. Serum and salivary CEA and GICA levels in oral cavity tumours. Int J Biol Markers 1988 Apr-Jun; 3 (2): 107-112
41. Nagler R, Bahar G, Shpitzer T, et al. Concomitant analysis of salivary tumor markers: a new diagnostic tool for oral cancer. Clin Cancer Res 2006 Jul 1; 12 (13): 3979-3984 (Pubitemid 44078083)
42. Mizukawa N, Sugiyama K, Ueno T, et al. Defensin-1, an antimicrobial peptide present in the saliva of patients with oral diseases. Oral Dis 1999 Apr; 5 (2): 139-142 (Pubitemid 29198168)
43. Pickering V, Jordan RC, Schmidt BL. Elevated salivary endothelin levels in oral cancer patients: a pilot study. Oral Oncol 2007 Jan; 43 (1): 37-41 (Pubitemid 46162247)
44. Zhong LP, Zhang CP, Zheng JW, et al. Increased cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients. Arch Oral Biol 2007 Nov; 52 (11): 1079-1087 (Pubitemid 47503114)
45. Fernando D, Fowles J, Woodward A, et al. Legislation reduces exposure to second-hand tobacco smoke in New Zealand bars by about 90%. Tob Control 2007 Aug; 16 (4): 235-238
46. Lyons AJ, Cui N. Salivary oncofoetal fibronectin and oral squamous cell carcinoma. J Oral Pathol Med 2000 Jul; 29 (6): 267-270 (Pubitemid 30411215)
47. Hu S, Wong DT. Oral cancer proteomics. CurrOpin Mol Ther 2007 Oct; 9 (5): 467-476
48. Rhodus NL, Cheng B, Myers S, et al. The feasibility of monitoring NFkappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 2005 Oct; 44 (2): 77-82 (Pubitemid 41397172)
49. Brailo V, Vucicevic-Boras V, Cekic-Arambasin A, et al. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia. Oral Oncol 2006 Apr; 42 (4): 370-373
50. Zhang Y, Lin M, Zhang S, et al. NF-kappaB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population. Cytokine 2008 Feb; 41 (2): 144-149
51. Tao X, Huang Y, Li R, et al. Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 May; 103 (5): 661-669
52. Rhodus NL, Cheng B, Myers S, et al. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 2005 Mar; 114 (3): 278-283 (Pubitemid 40267669)
53. Jonsson R, Bolstad AI, Brokstad KA, et al. Sjogren's syndrome: a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci 2007 Jun; 1108: 433-447 (Pubitemid 47528757)
54. Motegi K, Azuma M, Tamatani T, et al. Expression of aquaporin-5 in and fluid secretion from immortalized human salivary gland ductal cells by treatment with 5-aza-20-deoxycytidine: a possibility for improvement of xerostomia in patients with Sjogren's syndrome. Lab Invest 2005 Mar; 85 (3): 342-353 (Pubitemid 40333151)
55. Witte T. Antifodrin antibodies in Sjogren's syndrome: a review. Ann N Y Acad Sci 2005 Jun; 1051: 235-239 (Pubitemid 41362752)
56. Ben-Chetrit E, Fischel R, Rubinow A. Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome. Clin Rheumatol 1993 Dec; 12 (4): 471-474 (Pubitemid 24021288)
57. Rhodus N, Dahmer L, LindemannK, et al. s-IgA and cytokine levels in whole saliva of Sjogren's syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study. Clin Oral Investig 1998 Dec; 2 (4): 191-196
58. Ryu OH, Atkinson JC, Hoehn GT, et al. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 2006 Sep; 45 (9): 1077-1086
59. Hu S, Wang J, Meijer J, et al. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome. Arthritis Rheum 2007 Nov; 56 (11): 3588-3600 (Pubitemid 350100692)
60. Halse AK, Marthinussen MC, Wahren-Herlenius M, et al. Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjogren's syndrome. Scand J Rheumatol 2000; 29 (1): 13-19 (Pubitemid 30096945)
61. Delaleu N, Immervoll H, Cornelius J, et al. Biomarker profiles in serum and saliva of experimental Sjogren's syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 2008; 10 (1): R22
62. Delaleu N, Madureira AC, Immervoll H, et al. Inhibition of experimental Sjogren's syndrome through immunization with HSP60 and its peptide amino acids 437-460. Arthritis Rheum 2008 Aug; 58 (8): 2318-2328
63. Mizukawa N, Sugiyama K, Ueno T, et al. Levels of human defensin-1, an antimicrobial peptide, in saliva of patients with oral inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999 May; 87 (5): 539-543
64. Cuida M, Halse AK, Johannessen AC, et al. Indicators of salivary gland inflammation in primary Sjogren's syndrome. Eur J Oral Sci 1997 Jun; 105 (3): 228-233 (Pubitemid 127759427)
65. Kleinegger CL, Stoeckel DC, Kurago ZB. A comparison of salivary calprotectin levels in subjects with and without oral candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 Jul; 92 (1): 62-67
66. Sweet SP, Denbury AN, Challacombe SJ. Salivary calprotectin levels are raised in patients with oral candidiasis or Sjogren's syndrome but decreased by HIV infection. Oral Microbiol Immunol 2001 Apr; 16 (2): 119-123
67. Sorsa T, Suomalainen K, Uitto VJ. The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases. Arch Oral Biol 1990; 35 Suppl.: 193-6S
68. Uitto VJ, Suomalainen K, Sorsa T. Salivary collagenase: origin, characteristics and relationship to periodontal health. J Periodontal Res 1990 May; 25 (3): 135-142 (Pubitemid 20217546)
69. Frodge BD, Ebersole JL, Kryscio RJ, et al. Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol 2008 Oct; 79 (10): 1913-1919
70. Ishikawa I. Host responses in periodontal diseases: a preview. Periodontol 2000. 2007; 43: 9-13
71. Miller CS, King Jr CP, Langub MC, et al. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J AmDent Assoc 2006 Mar; 137 (3): 322-329
72. Sorsa T, Mantyla P, Ronka H, et al. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N Y Acad Sci 1999 Jun 30; 878: 130-140 (Pubitemid 29353565)
73. Sorsa T, Tjaderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004 Nov; 10 (6): 311-318
74. Ingman T, Tervahartiala T, Ding Y, et al. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996 Dec; 23 (12): 1127-1132 (Pubitemid 126732090)
75. Herr AE, Hatch AV, Throckmorton DJ, et al. Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A 2007 Mar 27; 104 (13): 5268-5273
76. Makela M, Salo T, Uitto VJ, et al. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994 Aug; 73 (8): 1397-1406
77. Pederson ED, Stanke SR, Whitener SJ, et al. Salivary levels of alpha 2-macroglobulin, alpha 1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch Oral Biol 1995 Dec; 40 (12): 1151-1155
78. Nomura Y, Tamaki Y, Tanaka T, et al. Screening of periodontitis with salivary enzyme tests. J Oral Sci 2006 Dec; 48 (4): 177-183
79. Hormia M, Thesleff I, Perheentupa J, et al. Increased rate of salivary epidermal growth factor secretion in patients with juvenile periodontitis. Scand J Dent Res 1993 Jun; 101 (3): 138-144
80. Mogi M, Otogoto J, Ota N, et al. Interleukin 1 beta, interleukin 6, beta 2-microglobulin, and transforming growth factor-alpha in gingival crevicular fluid from human periodontal disease. Arch Oral Biol 1999 Jun; 44 (6): 535-539 (Pubitemid 29264475)
81. Salcetti JM, Moriarty JD, Cooper LF, et al. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofac Implants 1997 Jan-Feb; 12 (1): 32-42
82. Skaleric U, Kramar B, Petelin M, et al. Changes in TGF-beta 1 levels in gingiva, crevicular fluid and serum associated with periodontal inflammation in humans and dogs. Eur J Oral Sci 1997 Apr; 105 (2): 136-142 (Pubitemid 127780995)
83. Garito ML, Prihoda TJ, McManus LM. Salivary PAF levels correlate with the severity of periodontal inflammation. J Dent Res 1995 Apr; 74 (4): 1048-1056
84. Booth V, Young S, Cruchley A, et al. Vascular endothelial growth factor in human periodontal disease. J Periodontal Res 1998 Nov; 33 (8): 491-499 (Pubitemid 128527352)
85. Taichman NS, Cruchley AT, Fletcher LM, et al. Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis. Lab Invest 1998 Jul; 78 (7): 869-875 (Pubitemid 28347883)
86. Ohshima M, Fujikawa K, Akutagawa H, et al. Hepatocyte growth factor in saliva: a possible marker for periodontal disease status. J Oral Sci 2002 Mar; 44 (1): 35-39
87. Kaufman E, Lamster IB. The diagnostic applications of saliva: a review. Crit Rev Oral Biol Med 2002; 13 (2): 197-212
88. Dowling P, Wormald R, Meleady P, et al. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteomics 2008 Jul 21; 71 (2): 168-175 (Pubitemid 351915861)
89. Franzmann EJ, Reategui EP, Pedroso F, et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2007 Jul; 16 (7): 1348-1355
90. Streckfus CF, Bigler LR, Zwick M. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study. J Oral Pathol Med 2006 May; 35 (5): 292-300
91. Streckfus C, Bigler L, Dellinger T, et al. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res 2000 Jun; 6 (6): 2363-2370 (Pubitemid 30399204)
92. Streckfus C, Bigler L, Tucci M, et al. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest 2000; 18 (2): 101-109 (Pubitemid 30118402)
93. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002 Mar; 2 (3): 210-219
94. Giannobile WV, Al-Shammari KF, Sarment DP. Matrix molecules and growth factors as indicators of periodontal disease activity. Periodontol 2000 2003; 31: 125-134
95. Kaufman E, Lamster IB. Analysis of saliva for periodontal diagnosis: a review. J Clin Periodontol 2000 Jul; 27 (7): 453-465
96. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci 2007 Mar; 1098: 230-251
97. Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta 2004 May; 343 (1-2): 1-16
98. Hu Z, Zimmermann BG, Zhou H, et al. Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. Clin Chem 2008 May; 54 (5): 824-832 (Pubitemid 351671599)
99. Ballantyne J. Validity of messenger RNA expression analyses of human saliva [letter]. Clin Cancer Res 2007 Feb 15; 13 (4): 1350
100. Nussbaumer C, Gharehbaghi-Schnell E, Korschineck I. Messenger RNA profiling: a novel method for body fluid identification by real-time PCR. Forensic Sci Int 2006 Mar 10; 157 (2-3): 181-186 (Pubitemid 43243177)
101. Zubakov D, Hanekamp E, Kokshoorn M, et al. RNA markers for identification of blood and saliva stains revealed from whole genome expression analysis of time-wise degraded samples. Int J Legal Med 2008 Mar; 122 (2): 135-142 (Pubitemid 351170122)
102. Rosas SL, Koch W, da Costa Carvalho MG, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001 Feb 1; 61 (3): 939-942
103. Spafford MF, Koch WM, Reed AL, et al. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 2001 Mar; 7 (3): 607-612
104. Mager DL, Haffajee AD, Devlin PM, et al. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 2005; 3: 27
105. Pepe MS, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001 Jul 18; 93 (14): 1054-1061 (Pubitemid 32717537)
106. Li Y, Elashoff D, Oh M, et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 2006 Apr 10; 24 (11): 1754-1760 (Pubitemid 46622147)
107. Hart TC. Genetic considerations of risk in human periodontal disease. Curr Opin Periodontol 1994; 3-11
108. Hassell TM, Harris EL. Genetic influences in caries and periodontal diseases. Crit Rev Oral Biol Med 1995; 6 (4): 319-342
109. Hodge P, Michalowicz B. Genetic predisposition to periodontitis in children and young adults. Periodontol 2000 2001; 26: 113-134
110. Michalowicz BS. Genetic and heritable risk factors in periodontal disease. J Periodontol 1994 May; 65 (5 Suppl.): 479-488
111. Sofaer JA. Genetic approaches in the study of periodontal diseases. J Clin Periodontol 1990 Aug; 17 (7 Pt 1): 401-408 (Pubitemid 20231064)
112. Jordan WJ, Eskdale J, Lennon GP, et al. A non-conservative, coding singlenucleotide polymorphism in the N-terminal region of lactoferrin is associated with aggressive periodontitis in an African-American, but not a Caucasian population. Genes Immun 2005 Oct; 6 (7): 632-635 (Pubitemid 41637671)
113. Yoshie H, Tai H, Kobayashi T, et al. Salivary enzyme levels after scaling and interleukin-1 genotypes in Japanese patients with chronic periodontitis. J Periodontol 2007 Mar; 78 (3): 498-503
114. Takane M, Sugano N, Iwasaki H, et al. New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals. J Periodontol 2002 May; 73 (5): 551-554 (Pubitemid 34546408)
115. Sawamoto Y, Sugano N, Tanaka H, et al. Detection of periodontopathic bacteria and an oxidative stress marker in saliva from periodontitis patients. Oral Microbiol Immunol 2005 Aug; 20 (4): 216-220 (Pubitemid 40868394)
116. Aas JA, Paster BJ, Stokes LN, et al. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005 Nov; 43 (11): 5721-5732 (Pubitemid 41612354)
117. Greenstein G, Lamster I. Bacterial transmission in periodontal diseases: a critical review. J Periodontol 1997 May; 68 (5): 421-431 (Pubitemid 127521199)
118. Quirynen M, De Soete M, Dierickx K, et al. The intra-oral translocation of periodontopathogens jeopardises the outcome of periodontal therapy: a review of the literature. J Clin Periodontol 2001 Jun; 28 (6): 499-507 (Pubitemid 33761324)
119. Asikainen S, Alaluusua S, Saxen L. Recovery of A. actinomycetemcomitans from teeth, tongue, and saliva. J Periodontol 1991 Mar; 62 (3): 203-206
120. Mager DL, Haffajee AD, Socransky SS. Effects of periodontitis and smoking on the microbiota of oral mucous membranes and saliva in systemically healthy subjects. J Clin Periodontol 2003 Dec; 30 (12): 1031-1037
121. Paster BJ, Olsen I, Aas JA, et al. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000 2006; 42: 80-87
122. Umeda M, Contreras A, Chen C, et al. The utility of whole saliva to detect the oral presence of periodontopathic bacteria. J Periodontol 1998 Jul; 69 (7): 828-833 (Pubitemid 128524725)
123. Slots J. Microbiology in periodontics. Tandlaegebladet 1986 Oct; 90 (18): 794-798
124. Socransky SS. Relationship of bacteria to the etiology of periodontal disease. J Dent Res 1970 Mar-Apr; 49 (2): 203-222
125. Theilade E. The non-specific theory in microbial etiology of inflammatory periodontal diseases. J Clin Periodontol 1986 Nov; 13 (10): 905-911
126. van Palenstein Helderman WH. Microbial etiology of periodontal disease. J Clin Periodontol 1981 Aug; 8 (4): 261-280
127. Bolstad AI, Jensen HB, Bakken V. Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clin Microbiol Rev 1996 Jan; 9 (1): 55-71 (Pubitemid 26035539)
128. Kurata H, Awano S, Yoshida A, et al. The prevalence of periodontopathogenic bacteria in saliva is linked to periodontal health status and oral malodour. J Med Microbiol 2008 May; 57 (Pt 5): 636-642 (Pubitemid 351632912)
129. von Troil-Linden B, TorkkoH, Alaluusua S, et al. Salivary levels of suspected periodontal pathogens in relation to periodontal status and treatment. J Dent Res 1995 Nov; 74 (11): 1789-1795
130. Yoshida A, Kawada M, Suzuki N, et al. TaqMan real-time polymerase chain reaction assay for the correlation of Treponema denticola numbers with the severity of periodontal disease. Oral Microbiol Immunol 2004 Jun; 19 (3): 196-200 (Pubitemid 38649614)
131. Kulekci G, Leblebicioglu B, Keskin F, et al. Salivary detection of periodontopathic bacteria in periodontally healthy children. Anaerobe 2008 Feb; 14 (1): 49-54 (Pubitemid 351221364)
132. Sakai VT, Campos MR, Machado MA, et al. Prevalence of four putative periodontopathic bacteria in saliva of a group of Brazilian children with mixed dentition: 1-year longitudinal study. Int J Paediatr Dent 2007 May; 17 (3): 192-199
133. Sakamoto M, Huang Y, Ohnishi M, et al. Changes in oral microbial profiles after periodontal treatment as determined by molecular analysis of 16S rRNA genes. J Med Microbiol 2004 Jun; 53 Pt 6: 563-571 (Pubitemid 38803054)
134. Sakamoto M, Huang Y, Umeda M, et al. Detection of novel oral phylotypes associated with periodontitis. FEMS Microbiol Lett 2002 Nov 19; 217 (1): 65-69 (Pubitemid 35356545)
135. Sakamoto M, Takeuchi Y, Umeda M, et al. Application of terminal RFLP analysis to characterize oral bacterial flora in saliva of healthy subjects and patients with periodontitis. J Med Microbiol 2003 Jan; 52 (Pt 1): 79-89 (Pubitemid 36106373)
136. Sakamoto M, Umeda M, Ishikawa I, et al. Comparison of the oral bacterial flora in saliva from a healthy subject and two periodontitis patients by sequence analysis of 16S rDNA libraries. Microbiol Immunol 2000; 44 (8): 643-652 (Pubitemid 30671344)
137. Takeuchi Y, Umeda M, Sakamoto M, et al. Treponema socranskii, Treponema denticola, and Porphyromonas gingivalis are associated with severity of periodontal tissue destruction. J Periodontol 2001 Oct; 72 (10): 1354-1363 (Pubitemid 32998712)
138. Haffajee AD, Socransky SS. Microbiology of periodontal diseases: introduction. Periodontol 2000 2005; 38: 9-12
139. Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 2001 Oct; 14 (4): 727-752
140. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005; 38: 135-187
141. Moen K, Brun JG, Madland TM, et al. Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients. Clin Diagn Lab Immunol 2003 Nov; 10 (6): 1043-1050 (Pubitemid 37444271)
142. Moen K, Brun JG, Valen M, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006 Nov-Dec; 24 (6): 656-663 (Pubitemid 46138797)
143. Joshipura KJ, Douglass CW, Willett WC. Possible explanations for the tooth loss and cardiovascular disease relationship. Ann Periodontol 1998 Jul; 3 (1): 175-183
144. Meurman JH, Sanz M, Janket SJ. Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol Med 2004; 15 (6): 403-413 (Pubitemid 44567524)
145. Morrison HI, Ellison LF, Taylor GW. Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk 1999 Feb; 6 (1): 7-11 (Pubitemid 29170057)
146. Goldenberg RL, Culhane JF. Preterm birth and periodontal disease. N Engl J Med 2006 Nov 2; 355 (18): 1925-1927
147. Anttila T, Koskela P, Leinonen M, et al. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer 2003 Nov 20; 107 (4): 681-682 (Pubitemid 37296134)
148. Biarc J, Nguyen IS, Pini A, et al. Carcinogenic properties of proteins with proinflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis 2004 Aug; 25 (8): 1477-1484
149. Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004 Jul; 139 (7): 760-765 (Pubitemid 38886513)
150. Koyi H, Branden E, Gnarpe J, et al. An association between chronic infection with Chlamydia pneumoniae and lung cancer: a prospective 2-year study. APMIS 2001 Sep; 109 (9): 572-580 (Pubitemid 32929731)
151. Littman AJ, White E, Jackson LA, et al. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2004 Oct; 13 (10): 1624-1630
152. Mager DL. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med 2006; 4: 14
153. Huyghe A, Francois P, Charbonnier Y, et al. Novel microarray design strategy to study complex bacterial communities. Appl Environ Microbiol 2008 Mar; 74 (6): 1876-1885
154. Christodoulides N, Floriano PN, Miller CS, et al. Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann N Y Acad Sci 2007 Mar; 1098: 411-428 (Pubitemid 47092556)
155. Herr AE, Hatch AV, Giannobile WV, et al. Integrated microfluidic platform for oral diagnostics. Ann N Y Acad Sci 2007 Mar; 1098: 362-374
156. Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 2006 Mar; 137 (3): 313-321
157. Wong DT. Salivary diagnostics. Hoboken (NJ): Wiley-Blackwell, 2008
158. Wei F, Wang J, Liao W, et al. Electrochemical detection of low-copy number salivary RNA based on specific signal amplification with a hairpin probe. Nucleic Acids Res 2008 Jun; 36 (11): e65 (Pubitemid 351917548)
159. Wei F, Patel P, Liao W, et al. Electrochemical sensor for multiplex biomarkers detection. Clin Cancer Res 2009 Jul 1; 15 (13): 4446-4452